Deep venous thrombosis and venous thromboembolism prophylaxis

Keely L Buesing; Barghava Mullapudi; Kristin A Flowers

doi:10.1016/j.suc.2014.11.005

Deep venous thrombosis and venous thromboembolism prophylaxis

Surg Clin North Am. 2015 Apr;95(2):285-300. doi: 10.1016/j.suc.2014.11.005.

Authors

Keely L Buesing¹, Barghava Mullapudi², Kristin A Flowers²

Affiliations

¹ Division of Trauma & Surgical Critical Care, Department of General Surgery, University of Nebraska Medical Center, 983280 Nebraska Medical Center, Omaha, NE 68198-3280, USA. Electronic address: keely.buesing@unmc.edu.
² Division of Trauma & Surgical Critical Care, Department of General Surgery, University of Nebraska Medical Center, 983280 Nebraska Medical Center, Omaha, NE 68198-3280, USA.

PMID: 25814107
DOI: 10.1016/j.suc.2014.11.005

Abstract

"Venous thromboembolism (VTE) remains a significant risk for all surgical patients, despite validated guidelines. Development of VTE remains a high risk in hospitalized surgical patients, leading to complications in up to 30%. The stratification of patient risk factors and subsequent utilization of a validated prophylaxis and treatment regimen is, therefore, of utmost importance. Familiarity with the current guidelines and recommendations ultimately results in decreased morbidity, mortality, and health care costs. This article discusses the risk factors for developing VTE and management strategies based on the currently available guidelines."

Keywords: Deep venous thrombosis; Management strategies; Prophylaxis; Risk factors; Venous thromboembolism.

Publication types

Review

MeSH terms

Anticoagulants / therapeutic use
Clinical Protocols
Humans
Perioperative Care*
Postoperative Complications*
Pulmonary Embolism / etiology
Pulmonary Embolism / prevention & control*
Risk Factors
Venous Thromboembolism / etiology
Venous Thromboembolism / prevention & control*
Venous Thrombosis / etiology
Venous Thrombosis / prevention & control*

Substances

Anticoagulants